Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹1 Cr
Revenue (TTM)
₹25 Cr
Net Profit (TTM)
₹0 Cr
ROE
0 %
ROCE
2.9 %
P/E Ratio
--
P/B Ratio
--
Industry P/E
44.74
EV/EBITDA
30.5
Div. Yield
0 %
Debt to Equity
-2.3
Book Value
₹--
EPS
₹-2.3
Face value
10
Shares outstanding
3,143,400
CFO
--
EBITDA
--
Net Profit
--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
No Review & Analysis are available.
Manufacture of allopathic pharmaceutical preparations
Incorporated
1993
Chairman
--
Managing Director
Kamal Natvarlal Pandya
Headquarters
Vadodara, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Since, TTM earnings of Pan Drugs Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2014
|
0.00
|
0.00
|
|
2013
|
0.00
|
0.00
|
|
2012
|
0.00
|
0.00
|
|
2014
|
0.00
|
0.00
|
|
2013
|
0.00
|
0.00
|
The 52-week high and low of Pan Drugs Ltd are Rs -- and Rs -- as of 05-Apr-2026.
Pan Drugs Ltd has a market capitalisation of ₹ 1 Cr as on 26-Dec-2003. As per SEBI classification, it is a company.
Before investing in Pan Drugs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.